Abstract:Background: To elucidate the mechanisms by which Jolkinolide B (JB), derived from Euphorbia fischeriana, suppresses gastric cancer (GC) development, given its known potent antitumor effects and the lack of detailed understanding of its impact and molecular processes in GC. Methods: The study utilized both cellular and animal models to investigate the effects of JB on GC. The GC cell lines AGS and MKN45 were used to assess JB's impact on cell growth, proliferation, migration, and invasion. Molecular techniques, including molecular docking and dynamics simulations, were employed to explore the binding interactions between JB and caspase-8. The inhibitor Z-IETD-FMK was used to examine the role of caspase-8 in JB-mediated PANoptosis. Xenograft tumor transplantation experiments were conducted to evaluate JB's effect on tumor growth and biotoxicity in vivo. Results: JB markedly inhibited the growth, proliferation, migration, and invasion of the AGS and MKN45 GC cell lines. It induced PANoptosis in GC cells by activating caspase-8, leading to increased expression of cleaved caspase-3/7 (apoptosis), GSDMD-N (pyroptosis), and p-RIPK1 and p-MLKL (necroptosis). Molecular docking and dynamics simulations revealed that JB binds effectively to caspase-8 with a binding free energy (ΔTotal) of -34.41 kcal/mol, suggesting specific binding-induced caspase-8 activation. The inhibition of caspase-8 by Z-IETD-FMK prevented JB-mediated PANoptosis. Additionally, JB significantly reduced tumor growth in xenograft models without causing biotoxicity. Conclusion: JB is a promising bioactive agent that inhibits gastric cancer growth through the activation of the PANoptosis pathway. This study highlights JB's potential as an effective therapeutic option for GC, underlining the importance of its binding interaction with caspase-8 and subsequent activation of apoptotic, pyroptotic, and necroptotic pathways.

Jolkinolide B Targets Thioredoxin and Glutathione Systems to Induce ROS-mediated Paraptosis and Apoptosis in Bladder Cancer Cells.

Jolkinolide B sensitizes bladder cancer to mTOR inhibitors via dual inhibition of Akt signaling and autophagy

Jolkinolide B induces apoptosis of colorectal carcinoma through ROS-ER stress-Ca2+-mitochondria dependent pathway

Jolkinolide B induces apoptosis of colorectal carcinoma through ROS-ER stress-Ca 2+ -mitochondria dependent pathway.

Jolkinolide B Induces Apoptosis in MDA-MB-231 Cells Through Inhibition of the PI3K/Akt Signaling Pathway.

Jolkinolide B Inhibits Gastric Cancer Growth by Targeting the PANoptosis Molecular Switch Caspase-8

Thymol Inhibits Bladder Cancer Cell Proliferation Via Inducing Cell Cycle Arrest and Apoptosis

Thymoquinone Suppresses the Proliferation, Migration and Invasiveness through Regulating ROS, Autophagic Flux and miR-877-5p in Human Bladder Carcinoma Cells.

Parthenolide Induces Apoptosis And Cell Cycle Arrest Of Human 5637 Bladder Cancer Cells In Vitro

Β,β-Dimethylacrylshikonin Induces Mitochondria Dependent Apoptosis Through ERK Pathway in Human Gastric Cancer SGC-7901 Cells.

Natural Diterpenoid Eriocalyxin B Covalently Modifies Glutathione and Selectively Inhibits Thioredoxin Reductase Inducing Potent Oxidative Stress-Mediated Apoptosis in Colorectal Carcinoma RKO Cells.

A reactive oxygen species activation mechanism contributes to JS-K-induced apoptosis in human bladder cancer cells

A Nano-Traditional Chinese Medicine Against Lymphoma That Regulates the Level of Reactive Oxygen Species

Pro-apoptotic effects of JDA-202, a novel natural diterpenoid, on esophageal cancer through targeting peroxiredoxin I.

17-Hydroxy-Jolkinolide B Inhibits Signal Transducers And Activators Of Transcription 3 Signaling By Covalently Cross-Linking Janus Kinases And Induces Apoptosis Of Human Cancer Cells

Design, Synthesis, and Biological Evaluation of Benzo[B]Thiophene 1,1-Dioxide (BTP) Derivatives

Thymoquinone Induces Apoptosis in Bladder Cancer Cell Via Endoplasmic Reticulum Stress-Dependent Mitochondrial Pathway

Jolkinolide B attenuates laryngeal cancer cell growth and induces apoptosis via PTEN/PI3K/Akt signaling pathway

SKLB-163, a new benzothiazole-2-thiol derivative, exhibits potent anticancer activity by affecting RhoGDI/JNK-1 signaling pathway

Targeting Thioredoxin Reductase By Plumbagin Contributes To Inducing Apoptosis Of Hl-60 Cells

17-Acetoxyjolkinolide B Irreversibly Inhibits IκB Kinase and Induces Apoptosis of Tumor Cells